2024年第四季度Evogene GAAP每股收益为$0.06，或不可与$(0.72)预期相比，销售额为$161万，错失$363万预期

财报速递2025-03-06
Evogene（NASDAQ:EVGN）报告季度每股收益为$0.06，超过分析师共识预期的$(0.72)，高出108.33%。这比去年同期每股亏损$(1.30)增加了104.62%。公司报告季度销售额为$161万，未达到分析师共识预期的$363万，低了55.56%。这比去年同期的$57.8万增加了178.72%。

以上内容来自Benzinga Earnings专栏，原文如下：

Evogene (NASDAQ:EVGN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.72) by 108.33 percent. This is a 104.62 percent increase over losses of $(1.30) per share from the same period last year. The company reported quarterly sales of $1.61 million which missed the analyst consensus estimate of $3.63 million by 55.56 percent. This is a 178.72 percent increase over sales of $578.00 thousand the same period last year.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法